A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Strickler, JH; Niedzwiecki, D; Zemla, T; Cercek, A; Fakih, M; Ng, K; Sanchez, FA; Wu, CS-Y; Peterson, S; Bandel, L; Grothey, A; Bekaii-Saab, TS

Published Date

  • May 20, 2017

Published In

Volume / Issue

  • 35 / 15_suppl

Start / End Page

  • TPS3624 - TPS3624

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2017.35.15_suppl.tps3624